Merck, 1043580001, Benzonase® ELISA Kit III

General description
Benzonase ELISA Kit III was developed for the detection and quantitative determination of Benzonase® endonuclease.
Our SAFC® portfolio of high-quality raw materials for use in biopharmaceutical processing withstands strict quality control procedures plus the documentation and expertise to help our customers meet requirements as defined by the M-Clarity Program.

M-Clarity Program

Our comprehensive portfolio of downstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for production of classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. Ranging from non-GMP grades for low-risk application, to IPEC-PQG GMP for higher-risk applications, we have products covering all your manufacturing needs.
Application
The Benzonase ELISA Kit III was developed for the detection and quantitative determinationof Benzonase® endonuclease in samples from downstream processing where Benzonase® endonuclease is used as a process or purification aid. The assay allows the quantification of the presence of Benzonase® endonuclease down to concentrations of 0.1 ng/mL. Cross-reactions with standards cell culture supernatant are less than 1%. The kit uses purified polyclonal antibodies specific to Benzonase® endonuclease, which have been coated on to polystyrene microtiter plates.
Packaging
1.04358.0001 / 5 x 96 wells plates per kit

1.04358.0002 / 5 x 96 wells plates per kit
Legal Information
Benzonase is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany